|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-2-26
|
|
pubmed:abstractText |
Infliximab, a monoclonal antibody against tumor necrosis factor, is an effective maintenance therapy for patients with Crohn's disease without fistulas. It is not known whether infliximab is an effective maintenance therapy for patients with fistulas.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:AndersonFrank HFH,
pubmed-author:BernsteinCharles NCN,
pubmed-author:BlankMarion AMA,
pubmed-author:CheyWilliam YWY,
pubmed-author:FeaganBrian GBG,
pubmed-author:FedorakRichard NRN,
pubmed-author:KammMichael AMA,
pubmed-author:KorzenikJoshua RJR,
pubmed-author:LashnerBret ABA,
pubmed-author:MarstersPaul APA,
pubmed-author:OnkenJane EJE,
pubmed-author:RachmilewitzDanielD,
pubmed-author:RutgeertsPaulP,
pubmed-author:SandsBruce EBE,
pubmed-author:TraversSuzanne BSB,
pubmed-author:WildGaryG,
pubmed-author:WolfDouglas CDC,
pubmed-author:van DeventerSander JSJ
|
|
pubmed:copyrightInfo |
Copyright 2004 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
26
|
|
pubmed:volume |
350
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
876-85
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:14985485-Adult,
pubmed-meshheading:14985485-Aged,
pubmed-meshheading:14985485-Antibodies, Monoclonal,
pubmed-meshheading:14985485-Crohn Disease,
pubmed-meshheading:14985485-Cutaneous Fistula,
pubmed-meshheading:14985485-Double-Blind Method,
pubmed-meshheading:14985485-Drug Tolerance,
pubmed-meshheading:14985485-Female,
pubmed-meshheading:14985485-Gastrointestinal Agents,
pubmed-meshheading:14985485-Humans,
pubmed-meshheading:14985485-Infusions, Intravenous,
pubmed-meshheading:14985485-Intestinal Fistula,
pubmed-meshheading:14985485-Male,
pubmed-meshheading:14985485-Middle Aged,
pubmed-meshheading:14985485-Rectal Fistula,
pubmed-meshheading:14985485-Recurrence,
pubmed-meshheading:14985485-Remission Induction,
pubmed-meshheading:14985485-Treatment Outcome,
pubmed-meshheading:14985485-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Infliximab maintenance therapy for fistulizing Crohn's disease.
|
|
pubmed:affiliation |
Gastrointestinal Unit, Massachusetts General Hospital, and Harvard Medical School, Boston 02114, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|
